Pergoquin 1 mg Tablets for Horses

Appropriate endocrinologic laboratory tests should be conducted as well as
evaluation of clinical signs in order to establish a diagnosis of PPID.

Revised: September 2025
AN: 01107/2025Page 2 of 8

Special precautions for use in animals
As the majority of cases of PPID are diagnosed in aged horses, other pathological
processes are frequently present. For monitoring and frequency of testing, see
section 4.9.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Pergolide, like other ergot derivatives, may cause emesis, dizziness, lethargy or low
blood pressure. Severe adverse events such as collapse have been observed.
Ingestion may be harmful and associated with severe adverse events, especially in
children or people with pre-existing heart conditions. Do not ingest this veterinary
medicinal product. To avoid accidental ingestion, store and handle this veterinary
medicinal product separately away from human medicinal products and handle it with
great care. Tablet parts should be returned to the open blister space. Blisters should
be inserted back into the outer packaging and kept in a safe place. Tablets prepared
for administration should be administered immediately and not left unattended. In
case of accidental ingestion, seek medical advice immediately and show the package
leaflet or the label to the physician. Avoid driving or operating machinery following
ingestion of this veterinary medicinal product.
Children should not come into contact with the veterinary medicinal product.
This veterinary medicinal product may cause eye irritation, an irritating smell, or
headache after dividing the tablets. Avoid contact with the eyes and inhalation when
handling the tablets. Minimise exposure risks when dividing tablets, e.g. tablets
should not be crushed.
In case of contact with skin, wash exposed skin with water. In the event of eye
exposure, flush the affected eye immediately with water and seek medical advice.
For nasal irritation, move to fresh air and seek for medical attention if breathing
difficulty develops.
This veterinary medicinal product may cause hypersensitivity (allergy) reactions.
People with known hypersensitivity to pergolide or other ergot derivatives should
avoid contact with the veterinary medicinal product.
This veterinary medicinal product may cause adverse effects due to decreased
prolactin levels, which poses a particular risk to pregnant and lactating women.
Pregnant or lactating women should avoid dermal contact or hand-to-mouth contact
by wearing gloves when administering the veterinary medicinal product.
Do not eat, drink or smoke when using this veterinary medicinal product. Wash hands
after use.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

Revised: September 2025
AN: 01107/2025Page 3 of 8